Business
Press release: Availability of the Q1 2026 aide-mémoire
Availability of the Q1 2026 aide-mémoire Paris, France – March 24, 2026. Sanofi announced today the availability of its Q1 2026 aide-mémoire on the "Investors" page of the company's website: First quarter 2026 results (sanofi.com) Prepared each quarter, this document is intented to support financial modelling of the quarterly results. It covers non-comparable items, foreign currency impact, and share count. Sanofi's Q1 2026 results will be published on April 23, 2026. About Sanofi Sanofi is an R
About this update from Banco Santander, S.a.
[{"type":"image","alt":"Sanofi Winthrop Industrie","displaySize":"","headline":null,"caption":"Sanofi Winthrop Industrie","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":84,"url":"https://media.zenfs.com/en/globenewswire.com/c45c40f5ed741dd9c0f5c2f75b8fc137"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/739gYr0oCQk4PhnczLgzIQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExOA--/https://media.zenfs.com/en/globenewswire.com/c45c40f5ed741dd9c0f5c2f75b8fc137","width":300,"height":84}},"lazy":false},{"type":"text","content":"Availability of the Q1 2026 aide-mémoire","length":40,"tagName":"p"},{"type":"text","content":"Paris, France – March 24, 2026. Sanofi announced today the availability of its Q1 2026 aide-mémoire on the "Investors" page of the company's website:","length":163,"tagName":"p"},{"type":"text","content":"First quarter 2026 results (sanofi.com)","length":39,"tagName":"p"},{"type":"text","content":"Prepared each quarter, this document is intented to support financial modelling of the quarterly results. It covers non-comparable items, foreign currency impact, and share count. Sanofi's Q1 2026 results will be published on April 23, 2026.","length":245,"tagName":"p"},{"type":"text","content":"About Sanofi Sanofi is an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time.","length":648,"tagName":"p"},{"type":"text","content":"Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY.","length":50,"tagName":"p"},{"type":"text","content":"Media RelationsSandrine Guendoul | +33 6 25 09 14 25 | [email protected] Berland | +1 215 432 0234 | [email protected]éo Le Bourhis | +33 6 75 06 43 81 | [email protected] Rouault | +33 6 70 93 71 40 | [email protected] Timothy Gilbert | ...